IP Library Granted Patent US 11,180,743
Granted Patent B2
US 11,180,743 · App. 16/789,049 · Granted Nov 23, 2021

CasZ compositions and methods of use

Inventors: Jennifer A. Doudna (Berkeley, CA); David Burstein (Berkeley, CA); Janice S. Chen (Berkeley, CA); Lucas B. Harrington (Berkeley, CA); David Paez-Espino (Walnut Creek, CA); Jillian F. Banfield (Berkeley, CA)
Assignee: The Regents of the University of California
C12N9/22C12N15/11C12N15/113C07K2319/09C12N2310/20C12N2800/80
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,180,743
App. No.
16/789,049
Granted
Nov 23, 2021
Kind
B2
Abstract

Provided are compositions and methods that include one or more of: (1) a “CasZ” protein (also referred to as a CasZ polypeptide), a nucleic acid encoding the CasZ protein, and/or a modified host cell comprising the CasZ protein (and/or a nucleic acid encoding the same); (2) a CasZ guide RNA that binds to and provides sequence specificity to the CasZ protein, a nucleic acid encoding the CasZ guide RNA, and/or a modified host cell comprising the CasZ guide RNA (and/or a nucleic acid encoding the same); and (3) a CasZ transactivating noncoding RNA (trancRNA) (referred to herein as a “CasZ trancRNA”), a nucleic acid encoding the CasZ trancRNA, and/or a modified host cell comprising the CasZ trancRNA (and/or a nucleic acid encoding the same).

Claims (27)

1. A composition comprising a non-naturally occurring complex comprising:

(a) a CasZ polypeptide, or a nucleic acid encoding said CasZ polypeptide; and

(h) a non-naturally occurring CasZ guide RNA, or a nucleic acid encoding said non-naturally occurring CasZ guide RNA, wherein said CasZ guide RNA comprises a region that binds to the CasZ polypeptide and a guide sequence that is complementary to a target sequence of a target nucleic acid, and wherein the CasZ polypeptide comprises an amino acid sequence having 95% or more identity with SEQ ID NOS: 3, 8, or 12, and wherein the target nucleic acid is a eukaryotic DNA.

2. The composition of claim 1 further comprising a transactivating noncoding RNA.

3. The composition of claim 1 , further comprising the target nucleic acid.

4. The composition of claim 3 , wherein the target nucleic acid is single stranded DNA.

5. The composition of claim 4 , wherein the target nucleic acid lacks a PAM sequence.

6. The composition of claim 3 , wherein the target nucleic acid is double stranded DNA.

7. The composition of claim 1 , wherein the target nucleic acid is single stranded DNA.

8. The composition of claim 7 , wherein the target nucleic acid lacks a protospacer adjacent motif (PAM) sequence.

9. The composition of claim 1 , wherein the target nucleic acid is double stranded DNA.

10. The composition of claim 1 , further comprising a donor polynucleotide.

11. The composition of claim 1 , further comprising a cell.

12. The composition of claim 11 , wherein the cell comprises the CasZ polypeptide, or the nucleic acid encoding the CasZ polypeptide, and the non-naturally occurring guide nucleic acid, or the nucleic acid encoding the non-naturally occurring guide nucleic acid.

13. The composition of claim 11 , wherein he cell is a eukaryotic cell.

14. The composition of claim 1 , wherein the CasZ polypeptide is conjugated to a heterologous moiety.

15. The composition of claim 14 , wherein the heterologous moiety is a heterologous polypeptide.

16. The composition of claim 15 , wherein the heterologous polypeptide comprises a nuclear localization signal.

17. The composition of claim 1 , wherein the composition further comprises a second CasZ polypeptide, wherein the second CasZ polypeptide comprises an amino acid sequence having 95% or more identity with SEQ ID NOS: 3, 8, or 12.

18. A method of cleaving a target nucleic acid in a cell, the method comprising delivering into the cell a CasZ polypeptide and a non-naturally occurring guide nucleic acid comprising a region that binds to the CasZ polypeptide and a guide sequence that is complementary to a target sequence of the target nucleic acid, wherein the CasZ polypeptide and the guide nucleic acid form a complex

wherein the cleaving is performed by the complex,

and wherein said CasZ polypeptide comprises an amino acid sequence having 95% or more identity with SEQ ID NOS: 3, 8, or 12.

19. A composition comprising a complex comprising:

(a) a fusion polypeptide, or a nucleic acid encoding said fusion polypeptide, the fusion polypeptide comprising:

i) a CasZ polypeptide comprising an amino acid sequence having 95% or more identity with SEQ ID NOS: 3, 8, or 12; and

ii) a heterologous fusion partner; and

(b) a CasZ guide RNA, or a nucleic acid encoding said CasZ guide RNA, wherein said CasZ guide RNA comprises a region that binds to the CasZ polypeptide and a guide sequence that is complementary to a target sequence of a target nucleic acid.

Assignments (5)
CORRECTION BY DECLARATION TO CORRECT CONVEYANCE AND DOCUMENTS ERRONEOUSLY FILED AT 055223/0805 Recorded Sep 19, 2023
From: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 064953/0485 →
CORRECTION BY DECLARATION TO CORRECT CONVEYANCE AND DOCUMENTS ERRONEOUSLY FILED AT 057525/0141 Recorded Sep 19, 2023
From: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 064953/0509 →
CORRECTIVE BY NULLIFICATION TO CORRECT INCORRECTLY RECORDED APPLICATION/PATENT NUMBERS (SEE ATTACHMENT) AT REEL/FRAME 055223/0805. ASSIGNOR HEREBY CONFIRMS THE CHANGE OF ADDRESS. Recorded Sep 16, 2021
From: MAMMOTH BIOSCIENCES, INC.
To: MAMMOTH BIOSCIENCES, INC.
Reel/Frame 057525/0141 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 5, 2021
From: DOUDNA, JENNIFER A.; BURSTEIN, DAVID; CHEN, JANICE S.; HARRINGTON, LUCAS B.; PAEZ-ESPINO, DAVID; BANFIELD, JILLIAN F.
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 055512/0521 →
CHANGE OF ADDRESS OF THE ASSIGNEE Recorded Feb 4, 2021
From: MAMMOTH BIOSCIENCES, INC.
To: MAMMOTH BIOSCIENCES, INC.
Reel/Frame 055223/0805 →